MRI contrast agent developer Advanced Magnetics of Cambridge,MA, reported last week that it has received a $5 million milestonepayment from Berlex Laboratories due to Berlex's launch of FeridexIV, a liver-specific contrast agent developed by Advanced
MRI contrast agent developer Advanced Magnetics of Cambridge,
MA, reported last week that it has received a $5 million milestone
payment from Berlex Laboratories due to Berlex's launch of Feridex
IV, a liver-specific contrast agent developed by Advanced Magnetics
(SCAN 9/11/96).
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).